SCHEMBL20348570

SCHEMBL20348570

N=CNC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22174721 0.87
SCHEMBL12333361 0.86 ADH1B (0.38)
SCHEMBL23875823 0.86 ADH1B (0.38)
SCHEMBL21693889 0.84
SCHEMBL15220287 0.80
SCHEMBL20632109 0.68
SCHEMBL25463543 0.67 ADH1B (0.34)
SCHEMBL23555441 0.67
SCHEMBL21997344 0.64 ADH1B (1.00)
SCHEMBL1678136 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3562487-B1 METALLOENZYME INHIBITOR COMPOUNDS JI XING PHARMACEUTICALS HONG KONG LTD (HK) 2023-11-29 EP disclosed
WO-2018125800-A2 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) 2018-07-05 WO disclosed
US-20180186773-A1 METALLOENZYME INHIBITOR COMPOUNDS CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) 2018-07-05 US disclosed
CN-101287711-A Process for producing 1-substituted-5-acylimidazole compound UBE INDUSTRIES (JP) 2008-10-15 CN disclosed